My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.

    Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, Piguet V.

    PLoS Pathog. 2009 Sep;5(9):e1000574. Epub 2009 Sep 4.PMID: 19730691 [PubMed - in process]Related articlesFree article

    2.

    Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.

    Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Früh K, Moses AV.

    J Virol. 2009 Aug;83(16):7931-47. Epub 2009 Jun 10.PMID: 19515779 [PubMed - indexed for MEDLINE]Related articles

    3.

    Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

    Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli JC.

    PLoS Pathog. 2009 May;5(5):e1000450. Epub 2009 May 29.PMID: 19478868 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.

    Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y, Tanaka Y, Sata T, Tokunaga K.

    J Biol Chem. 2009 Oct 16. [Epub ahead of print]PMID: 19837671 [PubMed - as supplied by publisher]Related articlesFree article

    5.

    Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.

    Gupta RK, Hué S, Schaller T, Verschoor E, Pillay D, Towers GJ.

    PLoS Pathog. 2009 May;5(5):e1000443. Epub 2009 May 22.PMID: 19461879 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

    Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P.

    Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2886-91. Epub 2009 Jan 28.PMID: 19179289 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.

    Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana IB, Johnson WE, Westmoreland S, Evans DT.

    PLoS Pathog. 2009 May;5(5):e1000429. Epub 2009 May 15.PMID: 19436700 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu.

    Andrew AJ, Miyagi E, Kao S, Strebel K.

    Retrovirology. 2009 Sep 8;6:80.PMID: 19737401 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor.

    Goffinet C, Allespach I, Homann S, Tervo HM, Habermann A, Rupp D, Oberbremer L, Kern C, Tibroni N, Welsch S, Krijnse-Locker J, Banting G, Kräusslich HG, Fackler OT, Keppler OT.

    Cell Host Microbe. 2009 Mar 19;5(3):285-97.PMID: 19286137 [PubMed - indexed for MEDLINE]Related articles

    10.

    Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration.

    Gupta RK, Mlcochova P, Pelchen-Matthews A, Petit SJ, Mattiuzzo G, Pillay D, Takeuchi Y, Marsh M, Towers GJ.

    Proc Natl Acad Sci U S A. 2009 Oct 28. [Epub ahead of print]PMID: 19864625 [PubMed - as supplied by publisher]Related articles

    11.

    Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.

    McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, Johnson WE, Neil SJ, Bieniasz PD.

    PLoS Pathog. 2009 Feb;5(2):e1000300. Epub 2009 Feb 13.PMID: 19214216 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.

    Le Tortorec A, Neil SJ.

    J Virol. 2009 Nov;83(22):11966-78. Epub 2009 Sep 9.PMID: 19740980 [PubMed - in process]Related articles

    13.

    Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion.

    Miyagi E, Andrew AJ, Kao S, Strebel K.

    Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2868-73. Epub 2009 Feb 5.PMID: 19196977 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.

    Neil SJ, Zang T, Bieniasz PD.

    Nature. 2008 Jan 24;451(7177):425-30. Epub 2008 Jan 16.PMID: 18200009 [PubMed - indexed for MEDLINE]Related articles

    15.

    A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.

    Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, Thomas D, Strebel K, Benarous R.

    Mol Cell. 1998 Mar;1(4):565-74.PMID: 9660940 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of calcium-modulating cyclophilin ligand on human immunodeficiency virus type 1 particle release and cell surface expression of tetherin.

    Bego MG, Dubé M, Mercier J, Cohen EA.

    J Virol. 2009 Dec;83(24):13032-6. Epub 2009 Sep 30.PMID: 19793820 [PubMed - in process]Related articles

    17.

    CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.

    Schubert U, Antón LC, Bacík I, Cox JH, Bour S, Bennink JR, Orlowski M, Strebel K, Yewdell JW.

    J Virol. 1998 Mar;72(3):2280-8.PMID: 9499087 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species.

    Sato K, Yamamoto SP, Misawa N, Yoshida T, Miyazawa T, Koyanagi Y.

    Retrovirology. 2009 Jun 2;6:53.PMID: 19490609 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

    Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J.

    Cell Host Microbe. 2008 Apr 17;3(4):245-52. Epub 2008 Mar 13.PMID: 18342597 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Simian immunodeficiency virus SIVagm from African green monkeys does not antagonize endogenous levels of African green monkey tetherin/BST-2.

    Lim ES, Emerman M.

    J Virol. 2009 Nov;83(22):11673-81. Epub 2009 Sep 2.PMID: 19726508 [PubMed - in process]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity